Q&A: Fundamental Diseases
Anthony Hall from fundamental disease charity Findacure Development talks to IPT about the explosion of interest in treatments for rare conditions which has been driven by legislative incentives, and evaluates the future landscape
for Big Pharma.
Anthony Hall, Findacure Development, (September 2013)
Keywords: Fundamental diseases
Orphan drug legislation